Lineage Cell Therapeutics... (LCTX)
AMEX: LCTX
· Real-Time Price · USD
1.29
0.27 (26.47%)
At close: Aug 15, 2025, 1:32 PM
Lineage Cell Therapeutics Fail-to-Deliver
Total FTD Shares
111.59K
Above Average
FTD / Avg. Volume
4.64%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Lineage Cell Therapeutics Inc. has
111,588
shares failed to deliver, representing 4.64%
of the average daily volume of
2,406,146
shares. Over the past year, the monthly average FTD is
32,264
shares, with the current level 246% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 1.07 | 111.59K | -91.46% |
Jun 30, 2025 | 0.9074 | 1.31M | +8021.25% |
May 30, 2025 | 0.6647 | 16.09K | +12.36% |
Apr 25, 2025 | 0.49 | 14.32K | -93.29% |
Mar 26, 2025 | 0.5001 | 213.54K | +1978.26% |
Feb 28, 2025 | 0.5615 | 10.28K | -79.18% |
Jan 31, 2025 | 0.6007 | 49.36K | +2368.00% |
Dec 30, 2024 | 0.496 | 2K | -80.73% |
Nov 22, 2024 | 0.5039 | 10.38K | +109.07% |
Oct 24, 2024 | 0.8561 | 4.96K | -95.46% |
Sep 25, 2024 | 0.8857 | 109.32K | +5214.49% |
Aug 30, 2024 | 0.8839 | 2.06K | -92.06% |
Jul 30, 2024 | 1.02 | 25.91K | +166.60% |
Jun 28, 2024 | 0.9973 | 9.72K | -75.71% |
May 28, 2024 | 0.98 | 40K | +299.68% |
Apr 26, 2024 | 1.14 | 10.01K | +37.36% |
Mar 26, 2024 | 1.31 | 7.29K | +132.75% |
Feb 23, 2024 | 1.03 | 3.13K | -52.07% |
Jan 30, 2024 | 1 | 6.53K | +591.74% |
Dec 28, 2023 | 1.15 | 944 | -74.64% |
Nov 28, 2023 | 0.95 | 3.72K | +15408.33% |
Oct 31, 2023 | 1.14 | 24 | -97.60% |
Sep 29, 2023 | 1.18 | 1K | n/a |
Aug 14, 2023 | 1.42 | 1K | -53.53% |
Jul 31, 2023 | 1.53 | 2.15K | +340.98% |
Jun 22, 2023 | 1.48 | 488 | -12.70% |
May 31, 2023 | 1.26 | 559 | +43.33% |
Apr 25, 2023 | 1.32 | 390 | -92.17% |
Mar 29, 2023 | 1.44 | 4.98K | +155.80% |
Feb 01, 2023 | 1.4 | 1.95K | -50.71% |
Jan 30, 2023 | 1.44 | 3.95K | n/a |